NOSCH LABS PRIVATE LIMITED
Main Products & Services
- Enalapril Maleate
- Sumatriptan Succinate
- Intermediate Chemicals
- Sibutramine Hcl
- Tamsulosin Hcl
- Semi Finished Formulations
- Pharmaceutical Formulations
- Active Pharmaceutical Ingredients
- Almotriptan Malate
- Zolmitriptan
- Quetiapine Fumarate
- Lansoprazole
- Itraconazole
- Duloxetine Hcl
- Doxazosin Hcl
- Doxazosin Mesylate
- Pantoprazole Sodium Sesquihydrate
- Olanzapine(Form I Ii)
Contact Person
PRADIP CHOWDHURY G (DY.GM-MARKETING)
Telephone
91-*******4400
Mobile
994***2287
Fax
91-*******4406
Website
Address
Flat No. 404 to 406, Vijay Sai Towers OPP: BJP Office, Kukatpally
Company Introduction
'Making the world a healthier place'
This is the dream that drives us at Nosch. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel.
Over the past seven years, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain - APIs, Intermediates and Semi-finished Formulations.
Today, with an impeccable reputation for uncompromising quality and timely delivery, Nosch has emerged as the partner of choice of many transnational and multinational pharmaceutical companies in Asia, South America, Europe and the Middle East.
Production Prowess
Nosch's manufacturing operations span across 4 units in the south Indian state of Andhra Pradesh. While two are dedicated to API Unit, the other two are for Semi-finished Formulations/Pellets. The plants, built and operated in conformance with the latest cGMP norms, house R&D labs, technical services, quality control, quality assurance and regulatory affairs and are regularly inspected and approved by major customers from around the world.
The state-of-the-art equipment and instruments provide us the necessary competitive edge on the global state. Moreover, the infrastructure with its optimum installed capacities and capital costs, lends us a sustainable cost advantage.
R & D - An Eye to the Future
At present, our R&D activities are focused on process development. The sophisticated labs, manned by a talented, well-qualified team of professionals, develop proprietary processes for organic and custom-made intermediates. The department plays on active role in the selection of new products and charting non-infringing routes for manufacturing the same.
One of the main keys to Nosch's success has been the development and launch of products at the right time, in the right form and at the right price. An operation our R&D department enables us to perform to perfection, time after time!
Committed to Customer Delight
We believe in forging strong bonds with our customers through delivery of products on-time, cost--effectively and securely. Quick response time, comprehensive technical support and top-notch quality products have seen Nosch record a healthy turnover of 21 million, with export sales accounting for 16.2 million.
While the product portfolio is focused on Anti-ulceratives, which contribute to 50% of the company's turnover, we also have CTDs and Technical Documentation for many products.
Since the products are manufactured right from the basic to the penultimate stage, we are strategically positioned to supply any intermediate adhering to the customers specifications.
<b
This is the dream that drives us at Nosch. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel.
Over the past seven years, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain - APIs, Intermediates and Semi-finished Formulations.
Today, with an impeccable reputation for uncompromising quality and timely delivery, Nosch has emerged as the partner of choice of many transnational and multinational pharmaceutical companies in Asia, South America, Europe and the Middle East.
Production Prowess
Nosch's manufacturing operations span across 4 units in the south Indian state of Andhra Pradesh. While two are dedicated to API Unit, the other two are for Semi-finished Formulations/Pellets. The plants, built and operated in conformance with the latest cGMP norms, house R&D labs, technical services, quality control, quality assurance and regulatory affairs and are regularly inspected and approved by major customers from around the world.
The state-of-the-art equipment and instruments provide us the necessary competitive edge on the global state. Moreover, the infrastructure with its optimum installed capacities and capital costs, lends us a sustainable cost advantage.
R & D - An Eye to the Future
At present, our R&D activities are focused on process development. The sophisticated labs, manned by a talented, well-qualified team of professionals, develop proprietary processes for organic and custom-made intermediates. The department plays on active role in the selection of new products and charting non-infringing routes for manufacturing the same.
One of the main keys to Nosch's success has been the development and launch of products at the right time, in the right form and at the right price. An operation our R&D department enables us to perform to perfection, time after time!
Committed to Customer Delight
We believe in forging strong bonds with our customers through delivery of products on-time, cost--effectively and securely. Quick response time, comprehensive technical support and top-notch quality products have seen Nosch record a healthy turnover of 21 million, with export sales accounting for 16.2 million.
While the product portfolio is focused on Anti-ulceratives, which contribute to 50% of the company's turnover, we also have CTDs and Technical Documentation for many products.
Since the products are manufactured right from the basic to the penultimate stage, we are strategically positioned to supply any intermediate adhering to the customers specifications.
<b
Location Map
Companies with Similar Products
Indexim International
Active Pharmaceutical Ingredients,Agriculture products,Islamic cloths,Ayurvedic products,Dehydrated fruits and vegetable
Noble Drugs
Pharmaceutical Formulations,Ayurvedic Herbs,Cotton,Rice
ASCL GLOBAL
promotional items,cashew,Active Pharmaceutical Ingredients,Cashew Fenni,Fastners
LNT Europe
Broiler Hatching Egg,Layer Hatching Egg,Day Old Chicks,Fresh Egg,Premixes,Feed Additives,Veterinary Medicines,Disinfectants,Chemicals,Active Pharmaceutical Ingredients,Vitamins,Intermediate Chemicals,Agrochemicals,Pesticides,Insecticides,Fungicides,Herbicides,Fertilizers
Kanha health food services
herbal beauty cosmetics,dietary supplements,pharmaceutical formulations,organic foods
chinar global pvt ltd
Potato Flakes, Raw Sugar, Bulk Tea, Pharmaceutical Formulations, Plastic Packaging Materials, Glass Bottles
Changzhou New District Import Export Co., Ltd.
Enalapril maleate, captopril, rubber, accelerator, antioxidant
Saad Global Trade
Pharmaceutical Intermediate, Special Care Soap, Medicated Soap, Skin Care Soap, Active Pharmaceutical Ingredients, Pharmaceutical Machines, Textile Chemicals, Textile Machines, Food Addetives, Laboratories Equipment And Supplies
S.R.DRUGS INTERMEDIATE PVT LTD
Mono Chloro Acetic Acid,Sodium Mono Chloro Acetate,Methyl Chloro Actate,tri chloro acetyl chloride,chloro acetyl chloride,tetralone,methyl Chloro Acetate,3-amino acetophenone,3-nitro acetophenone,4-methyl sulphonyl acetophenone,4-methyl acetophenone,p-choloro benzo phenone,aceclofenac,cetirizene di hydro chloride,levo centirizene hydro chloride,pantoprazole sodium sesquihydrate,amlodipene base,amlodipene besolyte,2-acetyl 6-methoxy napthalene,3-hydroxy acetophenone
GRAND VENTURES PVT LTD
Plastics Containers,Pharmaceutical Formulations,Anti-Cancer Drugs Outsourced,Anti-Thyroid Drugs Outsourced,IV Fluids
© 2011-2026 Business-Yellowpages.com. All rights reserved.
Disclaimer: Business-Yellowpages is an information directory. We are not a transaction platform and do not handle payments. We encourage all buyers and suppliers to perform their own due diligence before entering business agreements